Sclerosteosis arises from mutations in the SOST gene, causing abnormally high bone mass and skeletal overgrowth, which can ...

As UCB marks 10 years in the UK with a special event at its research centre in Slough, Andrew McConaghie talks to chief executive Roch Doliveux about the company's future.

UCB already has an R&D base in Slough, Berkshire and the investment over the next five years will include £150-200 million to build a new research centre nearby. The company’s operation in ...

UCB is once again partnering with Sandra Lee — also known as Dr. Pimple Popper — for a campaign focused on elevating the awareness of hidradenitis suppurativa (HS). The drugmaker and healthcare ...

UNITED COMMUNITY BANKS ($UCB) posted quarterly earnings results on Tuesday, April 22nd. The company reported earnings of $0.59 per share, beating estimates of $0.57 ...

24 scientific abstracts reflect UCB's ongoing commitment to improving outcomes for people living with neurological conditions, including rare epilepsies Dravet syndrome and Lennox-Gastaut syndrome ...

UNITED COMMUNITY BANKS ($UCB) is expected to release its quarterly earnings data on Tuesday, April 22nd before market open, per Finnhub. Analysts are expecting ...

UCB Pharma Inc. has presented new preclinical data on their anti-α-synuclein antibody UCB-7853 for the potential treatment of PD.

UCB Investment Limited (UCBIL) has been recognised in three categories at the FinanceAsia Awards 2025, securing accolades for Best DCM House, Best ECM House, and Best Investment Bank. This marks ...